Bullish Moving Averages
8
Bearish Moving Averages
8
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1478.50Today’s High
1500.0052W low
996.5052W High
1582.00Open Price
1494.00Prev. Close
1477.0000Volume
446963.00Value
662667343.80Fundamentals
Market Cap Cr
119722.60
Price to Earnings
29.00
Price to Book Value
4.50
Dividend Yield
0.60
PE to Growth
0.60
Op Revenue TTM Cr
25774.09
Net Profit TTM Cr
4121.55
Cash From Operating Activity Cr
4133.91
Return on Equity %
15.43
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
02 Jul, 2024
64.5
Week
64.1
Month
56.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1486.88
PIVOT
First Resistance
1494.52
Second Resistance
1500.38
Third Resistance
1508.02
First Support
1481.02
Second Support
1473.38
Third Support
1467.52
Relative Strength Index
48.56
Money Flow Index
35.25
MACD
5.71
MACD Signal
15.71
Average True Range
28.36
Average Directional Index
19.2
Rate of Change (21)
2.86
Rate of Change (125)
19.45
Commodity Channel Index
-59.2
Williams %R
-80
BETA
1 Month
0.07
3 Month
0.22
1 Year
0.19
3 Year
0.04
PRICE CHANGE ANALYSIS
↓ -1.14%
1 Week
Low
High
1465.3
1507.2
↑ 2.45%
1 Month
Low
High
1418.55
1582
↓ -0.46%
3 Months
Low
High
1317.25
1582
↑ 15.69%
6 Months
Low
High
1266.2
1582
↑ 46.08%
1 Year
Low
High
996.5
1582
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 4575.27 | 4550.31 | 4869.81 | 4476.17 | 4013.45 | 4026.57 | 4243.55 | 3274.81 | 3262.92 | 4027.79 | 4132.76 | |
| Operating Expenses Qtr | 3208.77 | 3025.47 | 3285.60 | 3113.50 | 3093.96 | 2961.34 | 3090.22 | 2299.75 | 2558.96 | 2914.81 | 2952.21 | |
| Operating Profit Qtr | 827.89 | 1355.86 | 1379.12 | 1204.69 | 799.78 | 938.11 | 1061.05 | 857.38 | 387.65 | 1039.98 | 982.82 | |
| EBIDT Qtr Cr | 1422.87 | 1621.22 | 1584.21 | 1362.67 | 733.59 | 1065.23 | 1168.44 | 1090.22 | 880.62 | 1112.98 | 1180.55 | |
| Depreciation Qtr | 136.81 | 135.02 | 179.81 | 135.95 | 161.58 | 129.96 | 176.01 | 107.46 | 116.82 | 133.95 | 138.97 | |
| Net Profit Qtr | 1038.40 | 1114.14 | 1029.69 | 895.02 | 355.49 | 678.52 | 720.30 | 759.16 | 652.96 | 730.83 | 782.37 | |
| Basic EPS Qtr | 12.86 | 13.80 | 12.76 | 11.09 | 4.40 | 8.41 | 8.74 | 7.98 | 8.09 | 9.06 | 9.70 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 17645.00 | 16247.39 | 13758.49 | 14130.86 | 13552.00 | |
| Operating Expenses Annual Cr | 12090.19 | 11998.02 | 9725.32 | 10179.02 | 9951.86 | |
| Operating Profit Annual | 4484.15 | 3792.58 | 3366.47 | 3721.56 | 2707.29 | |
| Operating Profit Margin Annual % | 25.41 | 23.34 | 24.47 | 26.34 | 19.98 | |
| Total Expenses Annual Cr | 12698.03 | 12620.95 | 10212.26 | 10780.20 | 10587.69 | |
| EBIDT Annual Cr | 5554.81 | 4249.37 | 4033.17 | 3951.84 | 3600.14 | |
| EBIDT Annual margin % | 31.48 | 26.15 | 29.31 | 27.97 | 26.57 | |
| Depreciation | 587.59 | 595.91 | 460.01 | 556.11 | 599.78 | |
| PAT Before ExtraOrdinary Items Annual Cr | 3714.19 | 2469.53 | 2689.39 | 2468.28 | 2318.17 | |
| Net Profit Annual | 4077.25 | 2513.47 | 2957.93 | 2468.28 | 2318.17 | |
| Basic EPS Annual | 50.51 | 31.15 | 36.67 | 30.61 | 28.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 27973.92 | 24638.09 | 22513.55 | 19927.56 | 17402.96 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 217.06 | 258.64 | 206.94 | 344.24 | 383.41 | |
| Total Current Liabilities Annual Cr | 2862.25 | 2699.74 | 2728.56 | 2691.94 | 2619.29 | |
| Total Capital Plus Liabilities Annual Cr | 31053.23 | 27596.47 | 25449.05 | 22963.74 | 20405.66 | |
| Fixed Assets Annual | 4388.90 | 4313.25 | 3604.88 | 4421.56 | 4470.71 | |
| Total Non Current Assets Annual | 16146.43 | 14225.34 | 13424.42 | 12771.56 | 11378.60 | |
| Total Current Assets Annual | 14906.80 | 13371.13 | 12024.63 | 10192.18 | 9027.06 | |
| Total Assets Annual | 31053.23 | 27596.47 | 25449.05 | 22963.74 | 20405.66 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 897.09 | 975.31 | 1972.95 | 3121.80 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 3726.77 | 3035.05 | 2773.43 | 3460.31 | 2018.14 | |
| Cash from Investing Activity Annual | -2882.82 | -2757.95 | -2463.73 | -3360.45 | -1126.33 | |
| Cash from Financing Annual Activity | -708.83 | -424.77 | -426.72 | -65.80 | -693.89 | |
| Net Cash Flow Annual | - | -147.67 | -117.02 | 34.06 | 197.92 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 | |
| ROE Annual % | 14.57 | 10.20 | 13.13 | 12.38 | 13.32 | |
| ROCE Annual % | 17.61 | 14.67 | 15.72 | 16.75 | 16.86 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 33.51 | 26.91 | 30.80 | 28.42 | 28.43 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 6412.57 | 6788.44 | 6854.47 | 6465.18 | 5873.93 | 5924.53 | 5951.49 | 5478.62 | 5324.35 | 5570.15 | 5580.47 | |
| Operating Expenses Qtr | 4847.38 | 4856.28 | 4944.40 | 4834.98 | 4565.56 | 4402.54 | 4526.21 | 4231.84 | 4510.61 | 4247.89 | 4293.60 | |
| Operating Profit Qtr | 1315.86 | 1747.53 | 1733.75 | 1493.91 | 1173.74 | 1407.55 | 1302.33 | 1143.35 | 749.72 | 1230.97 | 1226.20 | |
| EBIDT Qtr Cr | 1565.19 | 1737.34 | 1910.07 | 1630.20 | 1125.95 | 1521.99 | 1425.28 | 1246.78 | 756.24 | 1322.26 | 1286.87 | |
| Depreciation Qtr | 288.34 | 233.43 | 290.04 | 239.21 | 346.22 | 272.11 | 299.37 | 254.41 | 290.31 | 247.47 | 253.06 | |
| Net Profit Qtr | 939.04 | 1055.90 | 1130.91 | 995.70 | 521.51 | 800.96 | 788.90 | 686.40 | 362.07 | 728.60 | 711.36 | |
| Basic EPS Qtr | 11.63 | 13.08 | 14.01 | 12.34 | 6.51 | 9.92 | 9.78 | 8.51 | 4.49 | 9.03 | 8.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 26520.66 | 23228.57 | 22044.25 | 19425.58 | 17476.19 | |
| Operating Expenses Annual Cr | 19483.04 | 17726.15 | 17210.56 | 14907.16 | 13926.00 | |
| Operating Profit Annual | 6291.05 | 5026.97 | 4552.78 | 4252.43 | 3205.99 | |
| Operating Profit Margin Annual % | 23.72 | 21.64 | 20.65 | 21.89 | 18.34 | |
| Total Expenses Annual Cr | 20623.94 | 19007.80 | 18368.86 | 16135.52 | 15298.01 | |
| EBIDT Annual Cr | 7037.62 | 5502.42 | 4833.69 | 4518.42 | 3550.19 | |
| EBIDT Annual margin % | 26.54 | 23.69 | 21.93 | 23.26 | 20.31 | |
| Depreciation | 1051.02 | 1172.11 | 1051.95 | 1067.66 | 1174.65 | |
| PAT Before ExtraOrdinary Items Annual Cr | 4155.31 | 2835.49 | 2559.47 | 2401.30 | 1546.98 | |
| Net Profit Annual | 4121.55 | 2801.91 | 2516.75 | 2404.87 | 1546.52 | |
| Basic EPS Annual | 51.01 | 34.69 | 31.17 | 29.79 | 19.16 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 26706.43 | 23407.78 | 20841.69 | 18326.53 | 15763.00 | |
| Minority Interest Liability Annual Cr | 95.90 | 305.76 | 275.69 | 259.06 | 294.28 | |
| Total Non Current Liabilities Annual Cr | 669.72 | 640.07 | 1070.53 | 1974.75 | 3212.14 | |
| Total Current Liabilities Annual Cr | 5245.77 | 5109.67 | 4913.21 | 4591.55 | 4393.14 | |
| Total Capital Plus Liabilities Annual Cr | 32717.82 | 29463.28 | 27101.12 | 25151.89 | 23662.56 | |
| Fixed Assets Annual | 7647.90 | 7269.92 | 7311.58 | 7477.12 | 7573.42 | |
| Total Non Current Assets Annual | 13276.41 | 12188.33 | 12373.58 | 11942.38 | 11956.38 | |
| Total Current Assets Annual | 19441.41 | 17274.95 | 14727.54 | 13209.51 | 11706.18 | |
| Total Assets Annual | 32717.82 | 29463.28 | 27101.12 | 25151.89 | 23662.56 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 1095.87 | 1291.24 | 1178.42 | 1382.19 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 4133.91 | 3237.65 | 3325.90 | 3755.20 | 3068.45 | |
| Cash from Investing Activity Annual | -2988.03 | -2388.51 | -1871.88 | -2387.18 | 104.04 | |
| Cash from Financing Annual Activity | -1200.43 | -958.29 | -1599.79 | -1329.90 | -2948.82 | |
| Net Cash Flow Annual | - | -109.15 | -145.77 | 38.12 | 223.67 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 331.98 | 293.79 | 261.74 | 230.46 | 199.16 | |
| ROE Annual % | 15.43 | 11.96 | 12.07 | 13.12 | 9.81 | |
| ROCE Annual % | 21.79 | 17.78 | 17.04 | 16.78 | 12.32 | |
| Total Debt to Total Equity Annual | 0.01 | 0.02 | 0.04 | 0.08 | 0.18 | |
| EBDIT Annual Margin % | 27.30 | 24.18 | 22.21 | 23.58 | 20.72 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| HDFC MUTUAL FUND | 4.47 | 75069903 | - | - |
| SBI MUTUAL FUND | 4.23 | 75069904 | - | - |
| GOVERNMENT PENSION FUND GLOBAL | 2.36 | 75069914 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| SOPHIE AHMED | 5.71 | 75069886 | 0 | 0 |
| M K HAMIED | 3.46 | 75069887 | 0 | 0 |
| SAMINA HAMIED | 2.22 | 75069888 | 0 | 0 |
| RUMANA HAMIED | 1.23 | 75069889 | 0 | 0 |
| SHIRIN HAMIED | 0.79 | 75069890 | 0 | 0 |
| Yusuf Khwaja Hameid | 18.68 | 75069898 | 0 | 0 |
| Kamil Hamied | 1.36 | 75069899 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HDFC MUTUAL FUND | 4.47 | 75069903 |
| SBI MUTUAL FUND | 4.23 | 75069904 |
| UTI | 1.11 | 75069905 |
| GOVERNMENT PENSION FUND GLOBAL | 2.36 | 75069914 |
| LIC | 3.67 | 75069907 |
| NPS Trust | 1.66 | 75069909 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 21, 2023 | 8.5 | FINAL | Jul 21, 2023 | Equity Share |
| Aug 08, 2022 | 5 | FINAL | Aug 10, 2022 | Equity Share |
| Aug 09, 2021 | 5 | FINAL | - | Equity Share |
| Mar 19, 2020 | 1 | SPECIAL | Mar 20, 2020 | Equity Share |
| Mar 19, 2020 | 3 | INTERIM | Mar 20, 2020 | Equity Share |
| Jul 31, 2019 | 3 | FINAL | - | Equity Share |
| Aug 13, 2018 | 3 | FINAL | - | Equity Share |
| Jul 26, 2017 | 2 | FINAL | - | Equity Share |
| Sep 12, 2016 | 2 | FINAL | - | Equity Share |
| Aug 11, 2015 | 2 | FINAL | - | Equity Share |
| Aug 06, 2014 | 2 | FINAL | - | Equity Share |
| Aug 06, 2013 | 2 | FINAL | - | Equity Share |
| Aug 01, 2012 | 2 | FINAL | - | Equity Share |
| Aug 09, 2011 | 2 | FINAL | - | Equity Share |
| Sep 03, 2010 | 0.8 | INTERIM | Sep 06, 2010 | Equity Share |
| Jul 23, 2010 | 2 | FINAL | - | Equity Share |
| Aug 10, 2009 | 2 | FINAL | - | Equity Share |
| Aug 12, 2008 | 2 | FINAL | - | Equity Share |
| Aug 08, 2007 | 2 | FINAL | - | Equity Share |
| Aug 18, 2006 | 2 | FINAL | - | Equity Share |
| Aug 19, 2005 | 3.5 | FINAL | - | Equity Share |
| Aug 19, 2004 | 3 | FINAL | - | Equity Share |
| Aug 22, 2003 | 10 | FINAL | - | Equity Share |
| Aug 14, 2002 | - | FINAL | - | Equity Share |
| Aug 06, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| May 11, 2004 | 10:2 | 2004-05-19 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 10, 2024 | Audited Results & Final Dividend | - |
| Jan 22, 2024 | Quarterly Results | (Revised) |
| Oct 27, 2023 | Quarterly Results | - |
| Jul 26, 2023 | Quarterly Results | - |
| May 12, 2023 | Audited Results & Final Dividend | - |
| Jan 25, 2023 | Quarterly Results | - |
| Nov 04, 2022 | Quarterly Results | - |
| Jul 29, 2022 | Quarterly Results | - |
| May 10, 2022 | Audited Results & Dividend | - |
| Jan 25, 2022 | Quarterly Results | - |
| Oct 26, 2021 | Quarterly Results | - |
| Aug 05, 2021 | Quarterly Results | - |
| May 14, 2021 | Audited Results & Dividend | - |
| Jan 29, 2021 | Quarterly Results | - |
| Nov 06, 2020 | Quarterly Results | - |
| Aug 07, 2020 | Quarterly Results | - |
| May 15, 2020 | Audited Results & Others | Inter-alia to Obtain an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Mar 12, 2020 | Interim Dividend | - |
| Feb 05, 2020 | Quarterly Results | - |
| Nov 06, 2019 | Quarterly Results | - |
| Aug 07, 2019 | Quarterly Results | - |
| May 22, 2019 | Others | inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Feb 06, 2019 | Quarterly Results | - |
| Nov 05, 2018 | Quarterly Results | - |
| Aug 08, 2018 | Quarterly Results | - |
| May 22, 2018 | Audited Results, Dividend & Others | Inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Feb 07, 2018 | Quarterly Results | - |
| Nov 07, 2017 | Quarterly Results | - |
| Aug 11, 2017 | Quarterly Results | - |
| May 25, 2017 | Audited Results & Dividend | - |
| Feb 08, 2017 | Quarterly Results | - |
| Dec 19, 2016 | Issue of Equity Shares | - |
| Nov 09, 2016 | Quarterly Results | - |
| Aug 12, 2016 | Quarterly Results | - |
| Jun 08, 2016 | Appointment of CFO | - |
| May 24, 2016 | Audited Results & Dividend | Recommended the appointment of Walker Chandiok & Co LLP, Chartered Accountants, as statutory auditors of the Company. |
| Feb 10, 2016 | Quarterly Results | - |
| Nov 05, 2015 | Quarterly Results | Re-appointed Mr. S. Radhakrishnan as a Whole-time Director for a term of two years with effect from November 12, 2015. |
| Aug 14, 2015 | Quarterly Results | - |
| Jul 09, 2015 | Appointment of Directors | - |
| May 29, 2015 | Audited Results & Dividend | - |
| Feb 12, 2015 | Quarterly Results | - |
| Nov 13, 2014 | Quarterly Results | - |
| Aug 14, 2014 | Quarterly Results | - |
| May 29, 2014 | Audited Results & Dividend | - |
| Feb 12, 2014 | Quarterly Results | - |
| Nov 13, 2013 | Quarterly Results | - |
| Aug 09, 2013 | Quarterly Results | - |
| May 29, 2013 | Audited Results & Dividend | - |
| Feb 06, 2013 | Quarterly Results | - |
| Nov 05, 2012 | Quarterly Results | - |
| Jul 31, 2012 | Quarterly Results | - |
| Jun 07, 2012 | Audited Results & Dividend | - |
| May 10, 2012 | Quarterly Results | - |
| Feb 13, 2012 | Quarterly Results | - |
| Nov 14, 2011 | Quarterly Results | - |
| Aug 05, 2011 | Quarterly Results | - |
| Jun 29, 2011 | Audited Results & Dividend | - |
| May 05, 2011 | Quarterly Results | - |
| Feb 04, 2011 | Quarterly Results | - |
| Nov 11, 2010 | Quarterly Results | - |
| Aug 25, 2010 | Special Interim Dividend & Others | To consider special interim dividend for the FY 2010-2011 & to approve the acquisition of Meditab Specialities Pvt. Ltd. for an aggregate consideration of Rs. 133.35 Crs. |
| Aug 13, 2010 | Quarterly Results | - |
| Jun 15, 2010 | Audited Results, Dividend & Others | For acquisition of 40% stake in a biotech Co. based in India through subscription of fresh Shares & 25% stake in a biotech Co. in Hong Kong through subscription of fresh Shares of the Company. |
| May 07, 2010 | Quarterly Results & Others | For acquisition of two manufacturing facilities which hitherto were manufacturing formulations and bulk drugs / intermediates exclusively for Cipla Ltd. for an aggregate consideration of Rs. 82.02 Cr. |
| Jan 28, 2010 | Quarterly Results | - |
| Oct 28, 2009 | Quarterly Results | - |
| Jul 29, 2009 | Quarterly Results & Others | To raise funds upto Rs 1500 Crs by further issue of securities in domestic / international markets through various instruments including equity shares / warrants with NCD's under QIPs / FCCBs & etc. |
| Jul 15, 2009 | Audited Results & Dividend | - |
| Apr 24, 2009 | Quarterly Results | - |
| Jan 22, 2009 | Quarterly Results | - |
| Oct 22, 2008 | Quarterly Results | - |
| Jul 18, 2008 | Audited, Quarterly Results & Dividend | - |
| Apr 25, 2008 | Quarterly Results | - |
| Jan 24, 2008 | Quarterly Results | - |
| Oct 24, 2007 | Quarterly Results | - |
| Jul 20, 2007 | Audited Results, Dividend & Qtr Results | - |
| Apr 26, 2007 | Quarterly Results | - |
| Jan 23, 2007 | Quarterly Results | - |
| Oct 20, 2006 | Quarterly Results | - |
| Jul 21, 2006 | Accounts, Dividend & Qtr Results | - |
| Apr 25, 2006 | Quarterly Results | - |
| Feb 11, 2006 | Bonus Issue & Issue of securities | Increase in the limit of investment by Foreign Institutional Investors into the paid-up capital / securities of the Company. |
| Jan 24, 2006 | Quarterly Results | - |
| Oct 27, 2005 | Quarterly Results | - |
| Jul 25, 2005 | Accounts, Dividend & Quarterly Results | - |
| Apr 26, 2005 | Quarterly Results | - |
| Jan 18, 2005 | Quarterly Results | - |
| Oct 26, 2004 | Quarterly Results | - |
| Jul 23, 2004 | Quarterly Results & Dividend | - |
| Apr 21, 2004 | Quarterly Results | - |
| Mar 23, 2004 | Stock Split | - |
| Jan 30, 2004 | Quarterly Results | - |
| Oct 31, 2003 | Quarterly Results | - |
| Jul 28, 2003 | Dividend & Quarterly Results | - |
| Apr 25, 2003 | Quarterly Results | - |
| Jan 18, 2003 | Quarterly Results | - |
| Oct 22, 2002 | Quarterly Results | - |
| Jul 24, 2002 | Accounts & Dividend | - |
| Apr 29, 2002 | Quarterly Results | - |
| Mar 04, 2002 | Interim Dividend | - |
| Jan 19, 2002 | Quarterly Results | - |
| Oct 20, 2001 | Quarterly Results | - |
| Jul 26, 2001 | Accounts, Dividend & Quarterly Results | - |
| Apr 26, 2001 | Quarterly Results | - |
| Jan 30, 2001 | Quarterly Results | - |
| Oct 24, 2000 | Quarterly Results | - |
| Jul 26, 2000 | Quarterly Results | - |
| Apr 27, 2000 | Quarterly Results | - |
| Mar 22, 2000 | Interim Dividend | - |
| Aug 06, 1999 | Bonus Issue | - |
| Jul 22, 1999 | Accounts, Dividend & Quarterly Results | - |
| Jan 28, 1999 | Quarterly Results | - |
| Oct 29, 1998 | Quarterly Results | - |
| Nov 14, 1997 | Half Yearly Results | - |
| Jul 24, 1997 | Accounts & Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Apr 24, 2006 | 3:2 | 2006-04-25 |
28 Jun 2024
CIPLA LTD. - 500087 - Dissolution Of Wholly Owned Step-Down Subsidiary
Dissolution of Cipla Dibcare (Pty) Limited i.e. wholly owned step-down subsidiary of the Company
27 Jun 2024
Cipla - Classification Of Goa Inspection Remains Key: Motilal Oswal
Comprehensive measures required to resolve regulatory issues
25 Jun 2024
CIPLA LTD. - 500087 - Update On USFDA Inspection At Company'S Manufacturing Facility In Patalganga, Maharashtra, India
Update on USFDA inspection at Company''s manufacturing facility in Patalganga, Maharashtra, India
24 Jun 2024
Cipla Hits Two-Week Low After FDA Flags Issues At Goa Facility
The stock declined as much as 3.02% during the day to Rs 1,495.05 apiece on the NSE.
21 Jun 2024
CIPLA LTD. - 500087 - USFDA Inspection At Company'S Manufacturing Facility In Goa, India.
USFDA inspection at Company''s manufacturing facility in Goa, India
21 Jun 2024
CIPLA LTD. - 500087 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BlackRock Inc
21 Jun 2024
Cipla, Sun Pharma ink non-exclusive agreement with Takeda on acid-reflux drug
Cipla and Sun Pharma will independently commercialise the drug in India under their respective trademark brands
19 Jun 2024
CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed the intimation for loss of share certificates
18 Jun 2024
Cipla invests additional 3 mn euro in mRNA technology company Ethris
The aim is to accelerate Cipla's entry into the mRNA space and deliver innovative mRNA-based therapies, particularly targeting respiratory treatments, to patients in emerging markets
18 Jun 2024
CIPLA LTD. - 500087 - Press Release- Cipla EU To Invest Additional EUR 3 Million In Ethris
Press Release- Cipla EU to invest additional EUR 3 million in Ethris
